NO307497B1 - Transdermalt terapeutisk system for administrering av galanthamin bestanddel - Google Patents
Transdermalt terapeutisk system for administrering av galanthamin bestanddelInfo
- Publication number
- NO307497B1 NO307497B1 NO952907A NO952907A NO307497B1 NO 307497 B1 NO307497 B1 NO 307497B1 NO 952907 A NO952907 A NO 952907A NO 952907 A NO952907 A NO 952907A NO 307497 B1 NO307497 B1 NO 307497B1
- Authority
- NO
- Norway
- Prior art keywords
- galanthamine
- pct
- administration
- transdermal therapeutic
- therapeutic system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4301783A DE4301783C1 (de) | 1993-01-23 | 1993-01-23 | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
PCT/EP1994/000054 WO1994016707A1 (de) | 1993-01-23 | 1994-01-10 | Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil |
Publications (3)
Publication Number | Publication Date |
---|---|
NO952907D0 NO952907D0 (no) | 1995-07-21 |
NO952907L NO952907L (no) | 1995-07-21 |
NO307497B1 true NO307497B1 (no) | 2000-04-17 |
Family
ID=6478781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952907A NO307497B1 (no) | 1993-01-23 | 1995-07-21 | Transdermalt terapeutisk system for administrering av galanthamin bestanddel |
Country Status (26)
Country | Link |
---|---|
US (1) | US5700480A (no) |
EP (1) | EP0680325B1 (no) |
JP (1) | JPH08505632A (no) |
KR (1) | KR100300477B1 (no) |
AT (1) | ATE216240T1 (no) |
AU (1) | AU679032B2 (no) |
CA (1) | CA2153572C (no) |
CZ (1) | CZ287053B6 (no) |
DE (2) | DE4301783C1 (no) |
DK (1) | DK0680325T3 (no) |
ES (1) | ES2176234T3 (no) |
FI (1) | FI113744B (no) |
HR (1) | HRP940028B1 (no) |
HU (1) | HU221165B1 (no) |
IL (1) | IL108235A (no) |
MY (1) | MY109926A (no) |
NO (1) | NO307497B1 (no) |
NZ (1) | NZ259857A (no) |
PH (1) | PH31473A (no) |
PL (1) | PL175083B1 (no) |
PT (1) | PT680325E (no) |
SI (1) | SI9400024A (no) |
SK (1) | SK281339B6 (no) |
WO (1) | WO1994016707A1 (no) |
YU (1) | YU48607B (no) |
ZA (1) | ZA94414B (no) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4429791C2 (de) * | 1994-08-23 | 1997-04-24 | Lohmann Therapie Syst Lts | Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung |
DE19509663A1 (de) | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Verfahren zur Isolierung von Galanthamin |
AU732803B2 (en) * | 1996-01-17 | 2001-05-03 | National Starch And Chemical Investment Holding Corporation | Adhesives resistant to skin-penetration enhancers |
AT402691B (de) * | 1996-01-26 | 1997-07-25 | Sanochemia Ltd | Verwendung von galanthamin zum herstellen von arzneimitteln zur behandlung von trisomie 21 oder verwandter trisomie-syndrome |
DE69735656T2 (de) * | 1996-07-15 | 2006-08-24 | Alza Corp., Mountain View | Vorrichtung zur transdermalen Verabreichung von Fluoxetin |
US6512010B1 (en) | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
DE19649534B4 (de) * | 1996-11-29 | 2004-05-06 | Lts Lohmann Therapie-Systeme Ag | Verpackung aus Verbundpackstoff zum Verpacken von wirkstoffhaltigen Pflastern |
DE19653605C2 (de) * | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
US6203817B1 (en) | 1997-02-19 | 2001-03-20 | Alza Corporation | Reduction of skin reactions caused by transdermal drug delivery |
US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US6193993B1 (en) * | 1998-03-03 | 2001-02-27 | Eisai Co., Ltd. | Suppository containing an antidementia medicament |
PL349501A1 (en) * | 1998-12-24 | 2002-07-29 | Janssen Pharmaceutica Nv | Controlled release galantamine composition |
US6241998B1 (en) | 1999-02-02 | 2001-06-05 | Acutek International | Dermatological patch |
DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
EP1221315A4 (en) * | 1999-10-13 | 2007-12-12 | Senju Pharma Co | ADHESIVE OPHTHALMIC PREPARATIONS FOR PERCUTANEOUS SPREADING |
WO2001043697A2 (en) * | 1999-12-10 | 2001-06-21 | Bonnie Davis | Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
US7445929B2 (en) * | 2000-05-26 | 2008-11-04 | Dainippon Sumitomo Pharma Co., Ltd. | Recombinant adenovirus vector having a reduced side effect |
FR2814368B1 (fr) * | 2000-09-26 | 2004-05-07 | Pf Medicament | Preparation pharmaceutique a base d'oxans |
DE10141652B4 (de) * | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
DE10235556A1 (de) * | 2002-08-03 | 2004-02-19 | Hf Arzneimittelforschung Gmbh | Medikament und Verfahren zur Verringerung des Alkohol- und/oder Tabakkonsums |
US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
CA2552114A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
US20050191349A1 (en) * | 2003-12-31 | 2005-09-01 | Garth Boehm | Galantamine formulations |
AT500143A1 (de) * | 2004-04-22 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
PT1895994E (pt) | 2005-05-13 | 2010-12-03 | Alza Corp | Sistema de administração de medicamentos de camada múltipla com barreira contra o fluxo de material do reservatório |
WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
DE102008059054A1 (de) | 2008-11-26 | 2010-05-27 | Otto Bock Pur Life Science Gmbh | Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung |
BR112013012156A2 (pt) | 2010-11-17 | 2017-12-05 | Hexal Ag | sistema terapêutico transdérmico e método de produção de um sistema terapêutico transdérmico |
KR101317158B1 (ko) | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
HRP20211377T1 (hr) | 2011-11-23 | 2022-01-07 | Therapeuticsmd, Inc. | Prirodne kombinirane hormonske supstitucijske formulacije i terapije |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
JP6285820B2 (ja) * | 2014-08-07 | 2018-02-28 | 久光製薬株式会社 | ガランタミン含有経皮吸収製剤 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
US20180008612A1 (en) * | 2016-07-11 | 2018-01-11 | Taho Pharmaceuticals Ltd. | Transdermal delivery system containing galantamine or salts thereof |
CA3155267A1 (en) | 2019-11-06 | 2021-05-14 | Thomas Hnat | Topical formulations of cyclooxygenase inhibitors and their use |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79183B (no) * | 1983-04-27 | 1984-10-02 | Lohmann Gmbh & Co Kg | |
US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
DE3843239C1 (no) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE4010079A1 (de) * | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | Pharmazeutische formulierung zur behandlung des alkoholismus |
DK0584185T3 (da) * | 1991-05-14 | 2000-02-07 | Ernir Snorrason | Behandling af træthedssyndrom med cholinesteraseinhibitorer |
-
1993
- 1993-01-23 DE DE4301783A patent/DE4301783C1/de not_active Expired - Lifetime
- 1993-12-30 IL IL10823593A patent/IL108235A/en not_active IP Right Cessation
-
1994
- 1994-01-10 AU AU58817/94A patent/AU679032B2/en not_active Ceased
- 1994-01-10 CZ CZ19951842A patent/CZ287053B6/cs not_active IP Right Cessation
- 1994-01-10 SK SK889-95A patent/SK281339B6/sk not_active IP Right Cessation
- 1994-01-10 PT PT94905024T patent/PT680325E/pt unknown
- 1994-01-10 CA CA002153572A patent/CA2153572C/en not_active Expired - Fee Related
- 1994-01-10 HU HU9501928A patent/HU221165B1/hu not_active IP Right Cessation
- 1994-01-10 WO PCT/EP1994/000054 patent/WO1994016707A1/de active IP Right Grant
- 1994-01-10 ES ES94905024T patent/ES2176234T3/es not_active Expired - Lifetime
- 1994-01-10 JP JP6516614A patent/JPH08505632A/ja active Pending
- 1994-01-10 NZ NZ259857A patent/NZ259857A/en not_active IP Right Cessation
- 1994-01-10 DE DE59410103T patent/DE59410103D1/de not_active Expired - Lifetime
- 1994-01-10 PL PL94309603A patent/PL175083B1/pl not_active IP Right Cessation
- 1994-01-10 AT AT94905024T patent/ATE216240T1/de active
- 1994-01-10 KR KR1019950703008A patent/KR100300477B1/ko not_active IP Right Cessation
- 1994-01-10 EP EP94905024A patent/EP0680325B1/de not_active Expired - Lifetime
- 1994-01-10 DK DK94905024T patent/DK0680325T3/da active
- 1994-01-10 US US08/495,609 patent/US5700480A/en not_active Expired - Lifetime
- 1994-01-17 MY MYPI94000112A patent/MY109926A/en unknown
- 1994-01-19 PH PH47631A patent/PH31473A/en unknown
- 1994-01-20 ZA ZA94414A patent/ZA94414B/xx unknown
- 1994-01-20 HR HRP4301783.5A patent/HRP940028B1/xx not_active IP Right Cessation
- 1994-01-21 SI SI9400024A patent/SI9400024A/sl unknown
- 1994-01-21 YU YU2694A patent/YU48607B/sh unknown
-
1995
- 1995-07-21 NO NO952907A patent/NO307497B1/no not_active IP Right Cessation
- 1995-07-21 FI FI953533A patent/FI113744B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO307497B1 (no) | Transdermalt terapeutisk system for administrering av galanthamin bestanddel | |
NO952908D0 (no) | Nitroglycerolholdig plaster, fremgangsmåte for fremstilling, samt anvendelse av plasteret | |
ES2105334T3 (es) | Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |